The anti-arthritic, anti-inflammatory, antioxidant activity and relationships with total phenolics and total flavonoids of nine South African plants used traditionally to treat arthritis by unknown
RESEARCH ARTICLE Open Access
The anti-arthritic, anti-inflammatory,
antioxidant activity and relationships with
total phenolics and total flavonoids of nine
South African plants used traditionally to
treat arthritis
Ishaku Leo Elisha1,2, Jean-Paul Dzoyem1,3, Lyndy Joy McGaw1, Francien S. Botha1 and Jacobus Nicolaas Eloff1*
Abstract
Background: Oxidative stress predisposes the human and animal body to diseases like cancer, diabetes,
arthritis, rheumatoid arthritis, atherosclerosis and chronic inflammatory disorders. Hence, this study seeks to
determine the antioxidant, anti-inflammatory and anti-arthritic activities of acetone leaf extracts of nine
South African medicinal plants that have been used traditionally to treat arthritis and inflammation.
Methods: The anti-inflammatory activity of the extracts was determined by investigating inhibition of nitric
oxide production in lipopolysaccharide activated RAW 264.7 macrophages as well as 15-lipoxygenase enzyme
inhibition. An anti-protein denaturation assay was used to determine the anti-arthritic properties of the
extracts. The antioxidant activity was determined using the 2,2-diphenyl-1-picrylhydrazyl (DPPH), 2,2′-azino-bis
(3-ethyl-benzthiazoline-6-sulfonic acid) (ABTS) radical scavenging assays and ferric reducing antioxidant power
(FRAP). The total phenolic and total flavonoid concentration of extracts were determined by using standard
methods.
Results: All extracts inhibited nitric oxide production in a dose-dependent manner in the LPS-stimulated RAW
264.7 macrophages. Extracts of Maesa lanceolata and Heteromorpha arborescens inhibited NO production by 99.16 %
and 89.48 % at a concentration of 30 μg/ml respectively. Elaeodendron croceum and Calpurnia aurea extracts had
strong activity against 15-lipoxygenase activity with IC50 values of 26.23 and 34.70 μg/ml respectively. Morus mesozygia
and Heteromorpha arborescens extracts had good in vitro anti-arthritic activity with IC50 values of 11.89 and 53.78 μg/ml,
the positive control diclofenac sodium had IC50 value of 32.37 μg/ml. The free radical scavenging activity of the extracts in
DPPH assays ranged between 7.72 and 154.77 μg/ml. Trolox equivalent antioxidant capacity (TEAC) and FRAP values
ranged from 0.06 to 1.32 and 0.06 to 0.99 respectively.
Conclusions: Results from this study support the traditional use of the selected medicinal plants in the management of
arthritis and other inflammatory conditions. The free radical scavenging capacity of the extracts may be related to an
immune boosting potential.
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Background
Free radicals or reactive oxygen species (ROS) are highly
unstable molecules produced by living organisms during
normal cellular metabolism [1]. A shift in the balance
between oxidants and antioxidants in favour of oxidants
is termed “oxidative stress” [2]. Oxidative stress is the
leading predisposing factor of diseases such as cancer,
diabetes, arthritis, rheumatoid arthritis, neurodegenerative
disorders, hypertension, atherosclerosis and chronic in-
flammatory disorders.
Reactive oxygen species act by oxidising polyunsaturated
fatty acids within cell membranes and lipoproteins via
metal ion-dependent hydroxyl radical formation causing
disruption of the cell membrane [3]. Proteins exposed to
free radical attack may fragment or aggregate, adversely
interfering with ion channels, cell receptors and oxidative
phosphorylation [4].
The antioxidant constituents of medicinal plants may
contribute to the protection of humans and animals
from a variety of metabolic and infectious diseases [2, 5].
The intake of natural antioxidants has been inversely
associated with morbidity and mortality from degenera-
tive disorders and other infections [6]. The determin-
ation of antioxidant capacity is reaction-mechanism
dependent and closely linked to the complex nature of
phytochemicals [7].
Clinical symptoms observed in tissue wounds and
other infectious diseases have been documented by
humans since antiquity [8]. Inflammation is the organism’s
response to the presence of pathogens, foreign body
lodgement in tissues or injurious chemicals. The activa-
tion of inflammatory cells, among them monocytes and
macrophages, which play an important role in innate
immunity is an early indicator of this process. These cells
are responsible for the appearance of the specific markers
of inflammation such as oedema, heat, redness, pain and
loss of function [8, 9]. Mediators of inflammation are
chemical substances released from injured or activated
macrophages that coordinate inflammatory responses.
Examples are nitric oxide (NO), leukotrienes, lipoxins and
prostaglandins [10].
The enzymatic action of nitric oxide synthase (NOS)
on L-arginine results in the production of NO. There
are two endothelial forms of NOS: Constitutive NOS
(cNOS) and inducible NOS (iNOS). During inflamma-
tion, the amount of NO produced by iNOS is greater
than that produced by cNOS [11]. Nitrite and nitrate are
stable metabolites of NO used as molecular markers to
indirectly determine the quantity of NO produced by
the cells [12]. Elevated nitric oxide synthesis after the in-
duced expression of NOS-2 by activated macrophages, is
one of the main cytostatic, cytotoxic and pro-apoptotic
mechanisms participating in the innate response in
many mammals [12, 13]. Evans and Stefanovic-Racic
[14] reported that osteoarthritic and rheumatoid joints
produce NO locally, and inhibitors of NO synthases have
strong anti-inflammatory activity.
Lipoxygenases (LOXs) are a group of oxidative en-
zymes with a non-heme iron atom in their active site.
They are involved in the regulation of inflammatory re-
sponses by the generation of pro-inflammatory mediators
known as leukotrienes or anti-inflammatory mediators
known as lipoxins [15]. In general, lipoxygenases are
classified as 5–, 8–, 12–, or 15-lipoxygenases according to
their selectivity in oxygenating fatty acids in a specific
position [16]. These enzymes catalyse the insertion of
oxygen into poly-unsaturated fatty acids (PUFAs) such as
arachidonic acid and linoleic acid. Lipoxygenases catalyse
the formation of hydroperoxyeicosatetraenoic acids
(HPETEs) from arachidonic acid. These HPETEs are sub-
sequently reduced and transformed to form eicosanoids,
which are involved in the development of rheumatoid
arthritis, psoriasis, asthmatic responses and glomerulo-
nephritis [15, 17].
Arthritis is a common problem observed in elderly
people. Nearly one-fifth of the world’s population suffers
from this debilitating disease [18]. The management of
arthritis and other inflammatory disorders involves the
use of different classes of drugs such as non-steroidal
anti-inflammatory drugs (NSAIDs), corticosteroids and
disease modifying anti-rheumatic drugs (DMARDs). The
use of NSAIDs has gastrointestinal side effects, which
includes irritation of the gastric mucosa, belching, gas-
tric ulceration and bleeding. Long-term use of NSAIDs
may impair renal and hepatic functions, predisposing
the patient to cardiovascular diseases [19]. Hence, there
is a continuous search for alternative drugs from plants
and other natural sources.
Plants are excellent sources of antioxidants, anti-arthritic
and anti-inflammatory agents [20, 21]. Pharmacological
properties of plant extracts are attributed to the presence of
phenols, flavonoids, tannins, flavonols, proanthocyanidins,
nitrogenous compounds, vitamins and terpenoids [5, 22].
The nine South African medicinal plants used in this
study were selected from the Phytomedicine database of
the University of Pretoria based on traditional use in the
treatment of arthritis, rheumatoid arthritis and other
forms of inflammatory disorders [23]. Hence, this study
aimed to investigate the validity of their traditional uses.
Methods
Chemicals and reagents
The chemicals we purchased from different suppliers
were: Linoleic acid (Merck, Darmstadt, Germany), xylenol
orange, ferric chloride (Searle Company, England), foetal
calf serum (FCS), penicillin/streptomycin/fungizone (PSF)
and Dulbecco’s modified Eagle’s medium (DMEM)
(Highveld Biological, South Africa). Dulbecco’s phosphate
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buffered saline (PBS) (Lonza, Belgium), trypsin (Whitehead
Scientific, South Africa). Quercetin, 3-(4,5- dimethylthiazol-
2-yl)-2,5-diphenyl-tetrazolium bromide (MTT), sodium
dodecyl sulphate, sodium nitrite, ferrous sulfate, and
15-lipoxygenase (Glycine max) (Sigma, Germany) and
Tris(hydroxymethyl)aminomethane (Sigma, Switzerland),
diclofenac sodium, Bovine Serum Albumin (BSA) (Sigma,
St Louis USA). Sodium carbonate (Holpro Analytic, South
Africa) 2,2-azino-bis (3-ethylben- zothiazoline-6-sulfonic
acid) diammonium salt (ABTS), 2,2-diphenyl-1-picrylhydra-
zyl (DPPH), Folin–Ciocalteu reagent, gallic acid, 2,5,7,8-tet-
ramethylchroman carboxylic acid (Trolox), potassium
persulfate, glacial acetic acid, aluminium chloride, ascorbic
acid, hydrochloric acid, dimethyl sulfoxide (DMSO),
methanol and ethanol (Sigma-Aldrich St. Louis, MO,
USA). Potassium ferric cyanide and iron (II) sulphate
(Sigma, Germany).
Collection of plant material
The leaves of nine different South African medicinal
plants were collected from three locations namely the
University of Pretoria Botanical Garden, Pretoria
National Botanical Garden and Lowveld National Botan-
ical Garden in the summer of 2013. Voucher specimens
were prepared and deposited in the HGWJ Schweickerdt
Herbarium of the University of Pretoria. The plant spe-
cies with family and voucher specimen number in
brackets were: Hypericum roeperianum G.W. Schimp.ex
A. Rich. var. roeperianum, (Hypericaceae, PRU 120126),
Cremaspora triflora (Thonn.) K. Schum (Rubiaceae,
PRU 120129), Heteromorpha arborescens (Spreng.)
Chan. & Schltdl (Apiaceae, PRU 120026), Pittosporum
viridiflorum Sims (Pittosporaceae, PRU 120025), Bolu-
santhus speciosus (H. Bolus) Harms (Fabaceae, PRU
120027), Calpurnia aurea (Aiton) Benth ssp aurea
(Fabaceae, PRU 120125), Maesa lanceolata Forssk
(Maesaceae PRU120125), Elaeodendron croceum
(Thunb.) DC (Celastraceae, PRU 120127) and Morus
mesozygia Stapf ex A. Chev (Moraceae, PRU 120128).
Extraction
Acetone (technical grade, Merck) was used as an ex-
tractant in the assays using a ratio of 1:10 of pulverised
dried leaf material to extractant. Acetone is the best
choice as an extractant mainly due to its ability to ex-
tract compounds of a wide range of polarities [24], its
non-toxicity to bioassay systems [25] and ease of re-
moval from extracts. Three grams (3.0 g) of each tree
leaf sample were extracted with 30 ml acetone [26]. The
resulting suspension was vigorously shaken in 50 ml
polyester centrifuge tubes for 5 min and centrifuged at
4000 × g for 10 min (Hettich Centrifuge, Rotofix 32A,
Labotec, Johannesburg, South Africa). The extraction
was repeated two more times on the marc and
supernatants were decanted into preweighed glass vials
after filtering through Whatman No. 1 filter paper and
concentrated to dryness under a stream of cold air. The
dried extracts were stored at 5 °C in tightly stoppered glass
vials until use.
Assay of nitric oxide production and viability of
LPS- activated RAW 264.7 macrophages
Cell culture
The RAW 264.7 macrophage cells obtained from the
American Type Culture Collection (Rockville, MD,
USA) were cultured in a plastic culture flask in DMEM
containing L-glutamine supplemented with 10 % FCS
and 1 % PSF solution under 5 % CO2 at 37 °C. Cells
were seeded in 96 well microtitre plates and were
activated by incubation in medium containing LPS
(5 μg/ml) alone (control) or LPS with different concen-
trations (100, 30, 10 and 2 μg/ml) of the extracts dis-
solved in DMSO. Quercetin served as a positive control
NO inhibitor for the reduction of NO production [26].
Measurement of nitrite
Nitric oxide released from macrophages was determined
by measuring the nitrite concentration in culture super-
natant using the Griess reagent. After 24-h incubation,
100 μl of supernatant from each well of cell culture plates
was transferred into 96-well microtitre plates and an equal
volume of Griess reagent was added. The absorbance of
the resultant solutions was determined on a BioTek
Synergy microplate reader after 10 min at 550 nm. The
concentrations of nitrite were derived from regression
analysis using serial dilutions of sodium nitrite as a stand-
ard. Percentage inhibition was then calculated based on
the ability of compounds to inhibit nitric oxide formation
by cells compared with the control (cells in media without
extracts), which was considered as 0 % inhibition.
Determination of cell viability
To determine whether the observed nitric oxide inhibition
was not due to cytotoxicity, cytotoxicity was determined
on the culture as described by Mosmann [27], with slight
modifications. After removal of media, the cells were
topped up with 200 μl DMEM. To each well, 30 μl of
15 mg/ml MTT was added. The cells were incubated at
37 °C in 5 % CO2. After 2 h, the medium was carefully re-
moved and discarded and the formed formazan salt was
dissolved in DMSO. The absorbance was read at 570 nm
on a BioTek Synergy microplate reader. The percentage
cell viability was calculated with the control value (cells
without extracts containing LPS) taken as 100 % viability.
Determination of 15-lipoxygenase inhibitory assay
The assay was performed according to the method of Pinto
et al. [28] with slight modifications. The assay is based on
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measuring the formation of the complex Fe3+/xylenol or-
ange in a spectrophotometer at 560 nm. Lipoxygenase from
Glycine max was incubated with 25 μl extracts (final con-
centration 3.6–454.5 μg/ml) or a standard inhibitor (Quer-
cetin, final concentration 0.36–45.5 μg/ml) at 25 °C for
5 min. Then linoleic acid (final concentration, 140 mM) in
borate buffer (50 mM, pH 7.4) was added and the mixture
was incubated at 25 °C for 20 min in the dark. The assay
was terminated by the addition of 100 μl of FOX reagent
consisting of sulphuric acid (30 mM), xylenol orange
(100 mM), iron (II) sulfate (100 mM) in methanol/
water (9:1). For the negative control, only LOX solu-
tion and buffer were pipetted into the wells. Blanks
(background) contained the enzyme LOX during incu-
bation, the substrate (linoleic acid) was added to the
FOX reagent. The lipoxygenase inhibitory activity was
determined by calculating the percentage of inhibition
of hydroperoxide production from the changes in ab-
sorbance values at 560 nm after 30 min at 25 °C.
% inhibition ¼ ½ Acontrol–Ablankð Þ− Asample–Ablank
 
= Acontrol–Ablankð Þ  100:
Where, Acontrol is the absorbance of control well,
Ablank is the absorbance of blank well and Asample is the
absorbance of the sample well.
Anti-arthritic (protein denaturation assay)
Anti-arthritic activity of the extracts was determined
using the method of Sakat et al. [29] with minor modifi-
cations. The reaction mixture consisted of the 100 μl
test extracts (final concentration 9.77–1250 μg/ml) and
100 μl of 5 % aqueous solution of bovine serum albumin
(BSA); pH was adjusted adding a small volume of glacial
acetic acid. The sample extracts were incubated at 37 °C
for 20 min and then heated to 70 °C for 10 min. The
mixture was allowed to cool for 10 min after which
turbidity was measured at 660 nm. The blank comprised
the sample and distilled water. Distilled water was used
as the negative control. The positive control was diclofe-
nac sodium (final concentration 0.61–78. Percentage in-
hibition was calculated using the formula:
% inhibition ¼ 100  Abs Sample‐Blank=control‐1ð Þ
The IC50 was calculated from a graph of inhibition
against the different concentrations. The experiment was
carried out in triplicate.
The 2,2-azino-bis (3-ethylben- zothiazoline-6-sulfonic acid)
diammonium salt (ABTS) antioxidant assay
The quantitative ABTS radical scavenging capacity of
the extracts was measured using the 96 well microtitre
plate method described by Re et al. [30]. Trolox and
ascorbic acid were used as positive controls, methanol as
the negative control and extracts without ABTS as
blank. The absorbance was read at 734 nm exactly after
5 min of mixing. The percentage of ABTS• + inhibition
was calculated using the formula:
Scavenging capacity (%) = 100 - [(absorbance of the
sample - absorbance of the sample blank) × 100/ (absorb-
ance of control) – (absorbance of control blank)].
The IC50 values were calculated from the graph
plotted as inhibition percentage against the concentra-
tion. A Trolox standard curve was drawn by plotting
percentage inhibition of the ABTS+ radical against the
concentration of Trolox. Data from the test extracts
were analysed in a similar manner and the gradient
obtained was divided by the gradient of the Trolox re-
action to give a Trolox equivalent antioxidant capacity
(TEAC) value.
The 2,2-diphenyl-1-picrylhydrazyl (DPPH) antioxidant
scavenging assay
The DPPH radical scavenging activity of acetone extracts
was determined using the method described by Brand-
William et al. [31] based on the reduction of DPPH in
the presence of a hydrogen-donating antioxidant in
96-well microtitre plates. One hundred and sixty micro-
litres of the methanolic solution of DPPH (0.04 mg/ml,)
was added to 40 μl ascorbic acid and Trolox at concen-
trations of 1.0–200 μg/ml (positive controls), and different
concentrations of crude extracts (3.9–500 μg/ml). After
30 min, the absorbance was measured at 517 nm using a
Biotek microplate reader. The analysis was carried out in
triplicate, and the results were expressed as the percentage
reduction of the initial DPPH absorption in relation to the
control group. The concentration of extract that reduced
DPPH colour by 50 % (IC50) was determined using the
formula in the previous paragraph.
Ferric reducing antioxidant power (FRAP) assay
The FRAP of the nine acetone leaf extracts was deter-
mined by direct reduction of potassium ferricyanide
(K3Fe (CN)6) to potassium ferrocyanide (K4Fe(CN)6)
(electron transfer process from the antioxidant). The in-
crease in absorbance from the formation of Pearl’s Prus-
sian blue complex following the addition of excess ferric
ion was measured as described by Berker et al. [32] with
some modifications. The reaction medium (210 μl) con-
taining 40 μl of the test samples or positive controls
(Trolox and ascorbic acid; concentration range between:
15.62–2000 μg/ml); 100 μl of 1.0 M hydrochloric acid;
20 μl of 1 % (w/v) of SDS; 30 μl of 1 % (w/v) of potassium
ferricyanide, was incubated for 20 min at 50 °C, then
cooled to room temperature. Finally, 20 μl of 0.1 % (w/v)
of ferric chloride was added. The absorbance was read at
750 nm. The blank absorbance was prepared as above
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without the addition of ferric chloride. The TEAC (Trolox
Equivalent Antioxidant capacity) was calculated by divid-
ing the slope of each sample (slope obtained from the line
of best fit of the absorbance against concentration using
the linear regression curve) by that of Trolox.
Total phenolic content (TPC) determination
The total phenolic content (TPC) was determined color-
imetrically using a Folin-Ciocalteu 96-well microplate
assay developed by Zhang et al. [33]. The total phenolic
content was calculated from the linear equation of a
standard curve prepared with gallic acid and expressed
as Gallic Acid Equivalent (GAE) per g of extract.
Total flavonoid content (TFC) determination
Total flavonoid content was determined using the method
of Ordonez et al. [34]. A volume of 0.5 ml of 2 % AlCl3 in
ethanol solution was added to 0.5 ml of sample solution
(1 mg/ml). After one hour at room temperature, the ab-
sorbance was measured at 430 nm. A yellow colour is in-
dicative of the presence of flavonoids. Total flavonoid
content was calculated and expressed as mg quercetin
equivalent/g of crude extract using a standard curve pre-
pared with quercetin.
Statistical analysis
All experiments were conducted in triplicate and values
expressed as the mean ± standard deviation. Variations
in mean were calculated using one-way Analysis of vari-
ance (ANOVA), and means were statistically significant
if p <0.05. Post-Hoc analyses were carried out using
Tukey HSD or Dunnett Multiple comparison tests on
SPSS V.23 (Social Program for Social Sciences, SPSS
Corporation, Chicago, IL).
Results and Discussion
Antioxidant activities, total phenolic and flavonoid
contents of the tested extracts
DPPH is a stable organic free radical with an absorption
band at 517 nm. It loses the purple colour that absorbs
at this wavelength when accepting an electron or a free
radical species, which results in a yellow colour [35].
The extracts had varying degrees of antioxidant activity
in the DPPH assay. The IC50 values ranged between 7.72
and 154.77 μg/ml. Acetone leaf extracts of E. croceum,
M. lanceolata and H. roeperianum had good radical
scavenging activity with IC50 values of 7.72, 12.95 and
34.04 μg/ml respectively (Table 1). The IC50 value of a
compound is inversely related to its antioxidant capacity.
A lower IC50 value indicates a stronger antioxidant
activity of the extract or compound [36]. Ascorbic acid,
a known potent antioxidant, had the highest DPPH
scavenging activity (3.30 ± 0.06 μg/ml). E. croceum with
the highest level of total phenolics had the lowest IC50
value, higher than that of ascorbic acid but close to
Trolox (Table 1). Elaeodendron croceum had the highest
trolox equivalent antioxidant capacity (TEAC) value
(1.32), there was no statistical difference when the IC50
mean of E. croceum extracts was compared with trolox
(p > 0.05). Calpurnia aurea had the weakest antioxidant
capacity (0.06) in this assay (Table 1). The IC50 values
for ABTS assay ranged from 3.05 to 96.47 μg /ml.
Antioxidant activity of E. croceum acetone extracts com-
pared well with Trolox, p > 0.05 (Table 1). The trend for
the ferric reducing capacity of the extracts was similar to
those of the DPPH and TEAC. E. croceum showed the
highest reducing power (0.99) (Table 1).
Phenolics exert their antioxidant effects by decreasing
oxygen concentration, intercepting singlet oxygen, pre-
venting first chain initiation by scavenging initial radicals,
such as hydroxyl radicals, binding metal ion catalysts,
Table 1 Results of the quantitative phytochemical content analysis and antioxidant activity of the acetone leaf extracts of the nine
selected plants
Plant species TPC (GAE mg/g) TFC (QE mg/g) DPPH IC50 (μg/mL) ABTS IC50 (μg/mL) TEAC FRAP
Hypericum roeperianum 472.40 ± 1.15a 515.20 ± 1.53a 34.04 ± 0.25a 27.93 ± 2.98a 0.15 ± 0.02a 0.23 ± 0.03a
Cremaspora triflora 296.07 ± 5.86b 186.53 ± 2.65b 85.48 ± 2.17b 45.77 ± 1.67b 0.13 ± 0.02a 0.16 ± 0.02a
Heteromorpha arborescens 255.07 ± 5.03c 275.53 ± 4.58c 154.77 ± 4.07c 95.67 ± 2.91c 0.07 ± 0.01a 0.06 ± 0.00a
Pittosporum viridiflorum 423.40 ± 1.15d 389.20 ± 3.21d 50.29 ± 1.23d 58.40 ± 2.68d 0.09 ± 0.01a 0.25 ± 0.07a
Bolusanthus speciosus 377.73 ± 2.65e 726.20 ± 3.79e 115.12 ± 4.81e 59.96 ± 4.23d 0.10 ± 0.02a 0.07 ± 0.01a
Calpurnia aurea 308.07 ± 2.89f 285.20 ± 8.50c 170.40 ± 4.16f 96.47 ± 8.09e 0.06 ± 0.01a 0.07 ± 0.01a
Maesa lanceolata 669.07 ± 3.79g 223.53 ± 7.55f 12.95 ± 0.78g 9.64 ± 0.45f 0.70 ± 0.08b 0.15 ± 0.01a
Elaeodendron croceum 958.40 ± 1.53h 273.86 ± 5.03c 7.72 ± 0.27g,k 3.05 ± 0.27f 1.32 ± 0.17c 0.99 ± 0.08b
Morus mesozygia 375.07 ± 3.51e 657.53 ± 2.65g 106.98 ± 2.42h 45.5 ± 3.22b 0.14 ± 0.01a 0.18 ± 0.03a
Trolox NA NA 5.58 ± 0.05g,k 6.82 ± 0.99f 1.00 ± 0.00b,c 1 ± 0.00b
Ascorbic acid NA NA 3.30 ± 0.06k 2.92 ± 0.21f 2.32 ± 0.28d 3.67 ± 0.42c
Values with different letters are significantly different at p < 0.05; NA = Not Applicable
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decomposing primary products of oxidation to non-
radical species and breaking chains to prevent continued
hydrogen abstraction from substances [36, 37].
The total phenolic content of the acetone extracts
ranged from 255.07 to 958.40 mg GAE/g. E. croceum,
M. lanceolata and H. roeperianum, had the highest
amount of TPC, with values of 958.40, 669.07 and
472.40 mg gallic acid equivalent (GAE)/g respectively
(Table 1). There is a strong negative correlation when
the antioxidant activities of the extracts were compared to
their TPC values. For DPPH (r = − 0.79, p < 0.05), ABTS
(r = − 0.82, p < 0.05) indicating that the higher the total
phenolic content of the acetone extracts the lower their
IC50 values and therefore the highest the antioxidant
activity. There was a strong positive correlation
between TPC and TEAC (r = 0.96, p < 0.05) and FRAP
(r = 0.87, p > 0.05) values (Table 1). E. croceum had a
higher antioxidant capacity (1.32 ± 0.17) than trolox,
and a value of 0.99 ± 0.08 in the FRAP analysis. The
high TPC values of E. croceum, M. lanceolata and H.
roeperianum extracts are probably responsible for
their excellent antioxidant activities (Table 1).
The total flavonoid content (TFC) values ranged from
186.53 to 726.20 mg QE/g. Bolusanthus speciosus, Morus
mesozygia and Hypericum roeperianum had the highest
TFC (Table 1). There was a poor correlation between TFC
and antioxidant activity. For DPPH (r = 0.15, p > 0.05),
ABTS (r = 0.04, p > 0.05), TEAC (r = −0.34, p > 0.05) and
FRAP (r = −0.20, p > 0.05) indicating that the
antioxidant capacity of the extracts is not caused by
total flavonoid content (Table 1).
There were no statistically significant differences in
mean of the results obtained via DPPH and ABTS assays
(p > 0.05). This may imply that any one of the methods
would have given a representative value of the antioxi-
dant activity of the extracts. The results were compar-
able, probably due to a similarity in the mechanism of
scavenging activities of the extracts [38].
15-lipoxygenase inhibitory activity
Lipoxygenase enzymes in the cells of the body catalyse
the conversion of arachidonic acid to hydroperoxyeico-
satetraenoic acids (HPETEs), which are then reduced to
mono-HETEs or diHETEs and leukotrienes; these are
ranked amongst the most potent natural mediators of
hypersensitivity and inflammation [39]. A great number
of plant-derived constituents exhibit a pleiotropic
spectrum of anti-inflammatory actions [9]. The ferrous
oxidation-xylenol orange (FOX) assay was used to deter-
mine the 15-lipoxygenase inhibitory activity of the crude
extracts. The results presented in Figure 1 indicate that
all the extracts have varying degrees of inhibitory activity
against 15-lipoxygenase, thus supporting claims of their
use in the management of arthritis, aches, pains, infec-
tions, rheumatism and other inflammatory disorders
[23]. The IC50 values of the extracts ranged from 26.23
to 91.77 μg/ml respectively. E. croceum and C. aurea
acetone crude extracts had very good activity against the
15-lipoxygenase enzyme, with IC50 values of 26.23 and
34.70 μg/ml respectively. These extracts compared better
than the positive control quercetin which had IC50 value
of 53.69 μg/ml. Bolusanthus speciosus and Cremaspora
triflora also had promising inhibitory anti-inflammatory
activities, with both IC50 values < 50 μg/ml (Figure 1).
The observed variation in the strength of inhibition of 15-
lipoxygenase activity may be attributed to differences in
the phytochemical composition of the various extracts [9].
Generally, there was a strong, inverse correlation be-
tween the anti-lipoxygenase activity of E. croceum, C.
aurea, B. speciosus, and C. triflora and the phenolic
contents (r = −0.80, p < 0.05) of these extracts. The
promising anti-lipoxygenase activity of the acetone leaf
extracts of B. speciosus may be linked to the high con-
centration of flavonoids (Table 1 and Figure 1). Bojase et
al. [40] showed the presence of flavonoids in the stem
bark of B. speciosus. Flavonoids are known to interfere
with the different stages of the arachidonate cascade via
Figure 1 The anti-lipoxygenase activity of the acetone leaf extracts of the different plant species, showing the IC50 value of the extracts and quercetin.
* = Indicates significant difference compared to quercetin (p < 0.05), ** = Indicates significant difference compared to Quercetin(p < 0.01). HR = Hypericum
roeperianum, CT = Cremaspora triflora, HA = Heteromorpha arborescens, PV = Pittosporum viridiflorum, BS = Bolusanthus speciosus, CA = Calpurnia aurea,
ML =Maesa lanceolata, EC = Elaeodendron croceum, MM=Morus mesozygia
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Table 2 Inhibitory activities of the nine South African medicinal plants used traditionally in the management of different
inflammatory disorders on nitric oxide production and cell viability in LPS-activated RAW 264.7 macrophages
Plants Concentration (μg/mL) NO (μM) % NO inhibition % Macrophage viability
Hypericum roeperianum 100 2.46 ± 0.17 89.72 50.40
30 4.55 ± 0.25 81.04 89.40
10 8.28 ± 0.17 65.90 97.53
2 16.93 ± 1.43 29.41 100
Cremaspora triflora 100 6.15 ± 0.34 74.34 88.22
30 16.21 ± 0.25 32.39 89.71
10 18.36 ± 0.76 23.45 97.58
2 20.32 ± 1.52 15.26 100
Heteromorpha arborescens 100 0.08 ± 1.52 99.65 45.13
30 2.52 ± 0.08 89.48 82.12
10 7.52 ± 0.59 68.63 95.90
2 23.77 ± 0.17 0.87 100
Pittosporum viridiflorum 100 0.32 ± 0.17 98.66 95.66
30 4.67 ± 0.08 80.54 100
10 16.69 ± 0.25 30.40 100
2 24.43 ± 0.25 1.86 100
Bolusanthus speciosus 100 0.44 ± 0.84 98.16 34.25
30 9.25 ± 0.17 61.43 100
10 15.32 ± 0.17 36.11 98.35
2 19.55 ± 0.08 18.49 99.80
Calpurnia aurea 100 1.21 ± 0.25 94.94 60.27
30 18.60 ± 0.08 22.46 100
10 21.04 ± 0.00 12.29 96.50
2 23.30 ± 0.17 2.85 79.51
Maesa lanceolata 100 0.01 ± 0.00 100 9.29
30 0.20 ± 0.00 99.16 16.96
10 10.44 ± 0.17 56.47 22.12
2 12.58 ± 0.17 47.53 69.63
Elaeodendron croceum 100 1.21 ± 0.25 94.94 48.92
30 6.93 ± 0.25 71.11 69.65
10 14.31 ± 0.08 40.33 90.22
2 20.74 ± 0.42 13.53 >100
Morus mesozygia 100 0.20 ± 0.12 99.16 57.07
30 11.15 ± 0.12 53.49 100
10 20.68 ± 0.36 13.77 100
2 23.18 ± 0.12 3.35 95.05
Quercetin 100 0.79 ± 0.00 83.12 37.71
30 1.10 ± 0.00 100 51.89
10 1.40 ± 0.00 100 68.79
2 1.44 ± 0.00 100 66.30
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cyclooxygenase or lipoxygenase pathways to alleviate in-
flammatory responses [41].
Nitric oxide production and viability of LPS-activated
RAW 264.7 Macrophages
Nitric oxide (NO) has long been recognised as an
important molecule involved simultaneously in the
regulation of apoptotic death and cell viability [10]. Acti-
vation of RAW 264.7 macrophages with lipopolysacchar-
ide (LPS) induces the production of NO. The extent of
NO production is determined by measuring the concen-
tration of nitrite, a stable oxidised product of NO [42].
All extracts had a concentration-dependent inhibition of
NO production (Table 2). The good NO inhibitory activity
of M. lanceolata and B. speciosus at a concentration of
100 μg/ml is probably due to their toxicity to macrophages
with percentage cell viabilities of 9.29 % and 34.25 %
respectively (Table 2). The extracts of Heteromorpha
arborescens and Hypericum roeperianum at 30 μg/ml
and 10 μg/ml had significant NO inhibitory activity.
In addition, extracts of M. lanceolata inhibited NO
production by 47.53 % at the lowest concentration
(2 μg/ml). The capacity of the extracts to inhibit NO
production may be attributed to their phenolic con-
tents. Phenols regulate the synthesis of inducible
nitric oxide synthase (iNOS) by inhibiting the nuclear
transcription factor NFkappaB [43]. Many natural
compounds from medicinal plants inhibit the expres-
sion of iNOS in LPS-activated macrophages. For ex-
ample, phenolics isolated from Yucca schidigera have
antioxidant and free-radical scavenging capacity,
which aid in suppressing reactive oxygen species that
stimulate inflammatory response [43].
In vitro anti-arthritic activity
The anti-denaturation study for investigating anti-
arthritis activity was performed using bovine serum
albumin (BSA). When BSA is heated, it undergoes
denaturation and antigens are expressed which are asso-
ciated with type-III hypersensitivity reaction, which in
turn is related to diseases such as serum sickness, glom-
erulonephritis, rheumatoid arthritis and systemic lupus
erythematosus [44]. All the extracts had a dose-
dependent response in the in vitro anti-arthritic test.
The IC50 ranged from 11.89 to 254 μg/ml. M. mesozygia
and H. arborescens had good anti-denaturation activity
(Figure 2), with IC50 values of 11.89 and 53.74 μg/ml
respectively. M. mesozygia extracts were three times
more effective than the positive control, diclofenac
sodium (IC50 = 32.37 μg/ml). The promising activities of
the extracts support the traditional claims of use as rem-
edies for arthritis, rheumatism and other chronic inflam-
matory conditions [23]. Denaturation of protein is one
of the causes of rheumatoid arthritis. Production of
autoantigen in certain arthritic diseases may be due to
denaturation of protein. The mechanism of denaturation
probably involves alteration of electrostatic, hydrogen,
hydrophobic and disulphide bonds [45].
Conclusions
The in vitro study of the acetone leaf extracts of the nine
selected plants revealed promising antioxidant, anti-
inflammatory and anti-arthritic activity. The study corrobo-
rates traditional claims of the use of these South Africans
medicinal plants in the management of arthritis, infections,
rheumatism and inflammation. The plants have potential
for development as therapeutic agents of inflammation and
other autoimmune disorders, but safety will have to be ex-
amined in more detail. Since the mechanism of action of
these extracts has not been elucidated, it is recommended
to investigate this aspect as part of the on-going drug devel-
opment process. It may be interesting to correlate the activ-
ities with the chemical composition of the different plant
extracts to determine if other correlations exist.
Figure 2 The protein anti-denaturation activity of acetone leaf extracts of different plant species, showing the IC50 values of the extracts
and Diclofenac sodium. * = indicates significant difference in mean, when the diclofenac sodium was compared to the extracts(p < 0.05), ** = indicates
significant difference in mean of extract compared to diclofenac sodium, (p < 0.01). HR = Hypericum roeperianum, CT = Cremaspora triflora,
HA = Heteromorpha arborescens, PV = Pittosporum viridiflorum, BS = Bolusanthus speciosus, CA = Calpurnia aurea, ML =Maesa lanceolata,
EC = Elaeodendron croceum, MM =Morus mesozygia, DS = Diclofenac sodium
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